ASH 2022 Mezigdomide (CC-92480) + Dex in R/R MM: Preliminary Results From the Dose Expansion Phase of the CC-92480-MM-001 Trial
By
ASH 2022 Conference Coverage
FEATURING
Paul Richardson
By
ASH 2022 Conference Coverage
FEATURING
Paul Richardson
Login to view comments.
Click here to Login